dihexa retracted paper controversy Two and a half years after findings of misconduct, stem cell researchers up to 19 retractions – Retraction Watch Scientist who publishes more than

This study is the first preclinical pharmacokinetic study of BPC157, and the results are of considerable importance, as they demonstrate not only the pharmacokinetic parameters of BPC157 but also show the implications for its systemic application as a novel drug for various injuries

Histological evaluations demonstrated more organized muscle architecture, while functional testing showed superior recovery of muscle performance compared with untreated controls (17)

A 2019 proof-of-concept study in Human Reproduction (Romero-Ruiz et al.) provided the earlier human data: kisspeptin treatment induced gonadotropic responses and rescued ovulation in a subset of women with PMOS, demonstrating direct clinical translation from the animal work

[7] Klicek, R., Sever, M., Radic, B., & Sikiric, P